OBJECTIVE: To determine the conversion rates to dementia in patients diagnosed with mild cognitive impairment (MCI) thought to be caused by incipient Alzheimer's disease (MCI-AD) or with MCI with features of vascular disease (MCI-Vas). METHODS: On the basis of patient history, neurocognitive, neurological and MRI evaluation, 99 patients were diagnosed with MCI-AD and 35 with MCI-Vas. Conversion to dementia over an average of a 2.4 +/- 1.8-year period was determined. RESULTS: Over the follow-up period, 44% converted to dementia, 51.5% remained classified as MCI, and 4.5% were reclassified as cognitively normal. The conversion rate to dementia was significantly faster at 3 years for the MCI-AD (50.5%) than for the MCI-Vas group (25.7%). The neuropsychological test found to best differentiate converters from non-converters was the Fuld-OME, a measure of learning and recall. Age, education, gender or APOE epsilon4 allele frequency did not differentiate converters from non-converters. CONCLUSIONS: MCI-AD and MCI-Vas are clinically meaningful subtypes of MCI that may convert to dementia at different rates. Prospective studies on larger subsets of MCI patients are required to confirm these findings. 2004 S. Karger AG, Basel
OBJECTIVE: To determine the conversion rates to dementia in patients diagnosed with mild cognitive impairment (MCI) thought to be caused by incipient Alzheimer's disease (MCI-AD) or with MCI with features of vascular disease (MCI-Vas). METHODS: On the basis of patient history, neurocognitive, neurological and MRI evaluation, 99 patients were diagnosed with MCI-AD and 35 with MCI-Vas. Conversion to dementia over an average of a 2.4 +/- 1.8-year period was determined. RESULTS: Over the follow-up period, 44% converted to dementia, 51.5% remained classified as MCI, and 4.5% were reclassified as cognitively normal. The conversion rate to dementia was significantly faster at 3 years for the MCI-AD (50.5%) than for the MCI-Vas group (25.7%). The neuropsychological test found to best differentiate converters from non-converters was the Fuld-OME, a measure of learning and recall. Age, education, gender or APOE epsilon4 allele frequency did not differentiate converters from non-converters. CONCLUSIONS:MCI-AD and MCI-Vas are clinically meaningful subtypes of MCI that may convert to dementia at different rates. Prospective studies on larger subsets of MCI patients are required to confirm these findings. 2004 S. Karger AG, Basel
Authors: Ranjan Duara; David A Loewenstein; Maria T Greig; Elizabeth Potter; Warren Barker; Ashok Raj; John Schinka; Amy Borenstein; Michael Schoenberg; Yougui Wu; Jessica Banko; Huntington Potter Journal: Am J Geriatr Psychiatry Date: 2011-11 Impact factor: 4.105
Authors: Jeannie-Marie S Leoutsakos; Alexandra L Bartlett; Sarah N Forrester; Constantine G Lyketsos Journal: Alzheimers Dement Date: 2013-08-15 Impact factor: 21.566
Authors: J A Luchsinger; A M Brickman; C Reitz; S J Cho; N Schupf; J J Manly; M X Tang; S A Small; R Mayeux; C DeCarli; T R Brown Journal: Neurology Date: 2009-08-11 Impact factor: 9.910
Authors: David R Weir; Robert B Wallace; Kenneth M Langa; Brenda L Plassman; Robert S Wilson; David A Bennett; Ranjan Duara; David Loewenstein; Mary Ganguli; Mary Sano Journal: Alzheimers Dement Date: 2011-01 Impact factor: 21.566
Authors: Ranjan Duara; David A Loewenstein; Maria Greig; Amarilis Acevedo; Elizabeth Potter; Jason Appel; Ashok Raj; John Schinka; Elizabeth Schofield; Warren Barker; Yougui Wu; Huntington Potter Journal: Am J Geriatr Psychiatry Date: 2010-04 Impact factor: 4.105
Authors: R Duara; D A Loewenstein; E Potter; J Appel; M T Greig; R Urs; Q Shen; A Raj; B Small; W Barker; E Schofield; Y Wu; H Potter Journal: Neurology Date: 2008-12-09 Impact factor: 9.910
Authors: Leonardo da Costa Lopes; Regina Miksian Magaldi; Mara Edwirges Rocha Gândara; Ana Carolina de Barros Reis; Wilson Jacob-Filho Journal: Dement Neuropsychol Date: 2007 Jul-Sep